The mammalian target of rapamycin, mTOR is the master regulator of a cell’s growth and metabolic state in response to nutrients, growth factors and many extracellular cues. Its dysregulation leads to a number of metabolic pathological conditions, including obesity and type 2 diabetes. Here, we review recent findings on the role of mTOR in major metabolic organs, such as adipose tissues, liver, muscle, pancreas and brain. And their potentials as the mTOR related pharmacological targets will be also discussed.
CITATION STYLE
Mao, Z., & Zhang, W. (2018, July 13). Role of mTOR in glucose and lipid metabolism. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms19072043
Mendeley helps you to discover research relevant for your work.